Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection

Dario Cattaneo, Sara Baldelli, Francesca Conti, Valeria Cozzi, Emilio Clementi

Research output: Contribution to journalArticle

Abstract

A high-performance liquid chromatographic method for the determination of linezolid in human plasma was developed and validated. After precipitation of plasma proteins with perchloric acid, the protein-free supernatant was separated by isocratic reverse-phase chromatography on a X Bridge C18 column. The mobile phase consisted of a mixture of phosphoric acid 0.05%: acetonitrile (75:25, v/v) with a flow rate of 1 mL/min. The column elute was monitored at 254 nm. The method was linear from 0.2 to 48 mg/L (mean r = 0.9996, n = 10). The observed intra-and inter-day assay imprecision ranged from 2.83% to 8.16% (18.80% at the lower limit of quantification); inaccuracy varied between-0.33% and 8.18%. Mean drug recovery was 99.8% for linezolid and 90.0% for the internal standard (para-toluic acid). The method was found to be precise and accurate and suitable for therapeutic drug monitoring of linezolid in routine clinical practice.

Original languageEnglish
Pages (from-to)520-524
Number of pages5
JournalTherapeutic Drug Monitoring
Volume32
Issue number4
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Linezolid
High Pressure Liquid Chromatography
Drug Monitoring
Reverse-Phase Chromatography
Blood Proteins
Acids
Pharmaceutical Preparations
Proteins

Keywords

  • HPLC
  • human plasma
  • linezolid
  • pharmacokinetics
  • therapeutic drug monitoring

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Medicine(all)

Cite this

Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection. / Cattaneo, Dario; Baldelli, Sara; Conti, Francesca; Cozzi, Valeria; Clementi, Emilio.

In: Therapeutic Drug Monitoring, Vol. 32, No. 4, 08.2010, p. 520-524.

Research output: Contribution to journalArticle

Cattaneo, Dario ; Baldelli, Sara ; Conti, Francesca ; Cozzi, Valeria ; Clementi, Emilio. / Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection. In: Therapeutic Drug Monitoring. 2010 ; Vol. 32, No. 4. pp. 520-524.
@article{bdf263f971a044878c1706bb8ee17c5b,
title = "Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection",
abstract = "A high-performance liquid chromatographic method for the determination of linezolid in human plasma was developed and validated. After precipitation of plasma proteins with perchloric acid, the protein-free supernatant was separated by isocratic reverse-phase chromatography on a X Bridge C18 column. The mobile phase consisted of a mixture of phosphoric acid 0.05{\%}: acetonitrile (75:25, v/v) with a flow rate of 1 mL/min. The column elute was monitored at 254 nm. The method was linear from 0.2 to 48 mg/L (mean r = 0.9996, n = 10). The observed intra-and inter-day assay imprecision ranged from 2.83{\%} to 8.16{\%} (18.80{\%} at the lower limit of quantification); inaccuracy varied between-0.33{\%} and 8.18{\%}. Mean drug recovery was 99.8{\%} for linezolid and 90.0{\%} for the internal standard (para-toluic acid). The method was found to be precise and accurate and suitable for therapeutic drug monitoring of linezolid in routine clinical practice.",
keywords = "HPLC, human plasma, linezolid, pharmacokinetics, therapeutic drug monitoring",
author = "Dario Cattaneo and Sara Baldelli and Francesca Conti and Valeria Cozzi and Emilio Clementi",
year = "2010",
month = "8",
doi = "10.1097/FTD.0b013e3181d5eeee",
language = "English",
volume = "32",
pages = "520--524",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection

AU - Cattaneo, Dario

AU - Baldelli, Sara

AU - Conti, Francesca

AU - Cozzi, Valeria

AU - Clementi, Emilio

PY - 2010/8

Y1 - 2010/8

N2 - A high-performance liquid chromatographic method for the determination of linezolid in human plasma was developed and validated. After precipitation of plasma proteins with perchloric acid, the protein-free supernatant was separated by isocratic reverse-phase chromatography on a X Bridge C18 column. The mobile phase consisted of a mixture of phosphoric acid 0.05%: acetonitrile (75:25, v/v) with a flow rate of 1 mL/min. The column elute was monitored at 254 nm. The method was linear from 0.2 to 48 mg/L (mean r = 0.9996, n = 10). The observed intra-and inter-day assay imprecision ranged from 2.83% to 8.16% (18.80% at the lower limit of quantification); inaccuracy varied between-0.33% and 8.18%. Mean drug recovery was 99.8% for linezolid and 90.0% for the internal standard (para-toluic acid). The method was found to be precise and accurate and suitable for therapeutic drug monitoring of linezolid in routine clinical practice.

AB - A high-performance liquid chromatographic method for the determination of linezolid in human plasma was developed and validated. After precipitation of plasma proteins with perchloric acid, the protein-free supernatant was separated by isocratic reverse-phase chromatography on a X Bridge C18 column. The mobile phase consisted of a mixture of phosphoric acid 0.05%: acetonitrile (75:25, v/v) with a flow rate of 1 mL/min. The column elute was monitored at 254 nm. The method was linear from 0.2 to 48 mg/L (mean r = 0.9996, n = 10). The observed intra-and inter-day assay imprecision ranged from 2.83% to 8.16% (18.80% at the lower limit of quantification); inaccuracy varied between-0.33% and 8.18%. Mean drug recovery was 99.8% for linezolid and 90.0% for the internal standard (para-toluic acid). The method was found to be precise and accurate and suitable for therapeutic drug monitoring of linezolid in routine clinical practice.

KW - HPLC

KW - human plasma

KW - linezolid

KW - pharmacokinetics

KW - therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=77955176621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955176621&partnerID=8YFLogxK

U2 - 10.1097/FTD.0b013e3181d5eeee

DO - 10.1097/FTD.0b013e3181d5eeee

M3 - Article

C2 - 20300050

AN - SCOPUS:77955176621

VL - 32

SP - 520

EP - 524

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 4

ER -